Investing.com - Joincare Pharm reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Joincare Pharm announced earnings per share of ¥0.17 on revenue of ¥4.45. Analysts polled by Investing.com EPS of ¥0.19 on revenue of ¥17,535M.
Joincare Pharm 's are down 11.7% and is trading at ¥12.02 , still down 12.33% from its 52 week high of ¥13.71 set on Friday, January 7, 2022.
Joincare Pharm shares gained 1.01% to trade at ¥12.02 in intra-day trade the report.
Joincare Pharm follows other major Healthcare sector earnings this month
Joincare Pharm's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar